Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
A Kaiser Permanente randomized controlled trial comparing an in-person diabetes prevention program with an online version found both helped San Francisco City and County employees at risk for developing diabetes to lose weight.
Pregnant women with overweight or obesity better controlled their weight gain and improved health behaviors when they received a series of telephone sessions with a registered dietician, a new study from Kaiser Permanente finds.
New findings from Kaiser Permanente Division of Research SWIFT Study in PLOS Medicine advance a potential blood test to predict which women with gestational diabetes will go on to develop type 2 diabetes.
New research by Kaiser Permanente shows the weekly number of patients admitted to Kaiser Permanente Northern California hospitals with acute myocardial infarction (heart attacks) fell to nearly half of what would be expected after the onset of the COVID-19 pandemic.
An analysis of 2.7 million Kaiser Permanente patients finds a higher risk of unhealthful drinking among people who drink and have chronic obstructive pulmonary disease (COPD), chronic liver disease, diabetes, and hypertension.
A new Kaiser Permanente research paper explains how Kaiser Permanente Northern California quickly ramped up its existing telehealth oncology program at the onset of the COVID-19 pandemic.
In the race to find safe and effective treatments for seriously ill patients with COVID-19, Kaiser Permanente Northern California (KPNC) is enrolling patients in nationwide clinical trials and pursuing other innovative treatment options.
A JAMA study, using data on patients hospitalized in March from all 21 Kaiser Permanente Northern California hospitals, is one of the first U.S. studies to look at overall hospitalization admissions of COVID-19 patients.
Kaiser Permanente Division of Research staff scientist Paola Gilsanz, ScD, is exploring the reasons for the unequal distribution of dementia risk among genders and ethnic groups.
A new study shows high success rates for experienced emergency physicians who use the sum of their clinical expertise to make an initial prediction about whether a child has appendicitis — especially in low-risk cases.